2 medical tech ASX shares Morgans loves right now
Growth shares have fallen out of favour with investors, but one investment house is keeping the faith in this pair of health device makers.
Stay updated with breaking news from Cochlear Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Growth shares have fallen out of favour with investors, but one investment house is keeping the faith in this pair of health device makers.
Cochlear Limited (OTCMKTS:CHEOY – Get Rating) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 9,000 shares, an increase of 95.7% from the March 31st total of 4,600 shares. Based on an average daily trading volume, of 12,500 shares, the short-interest ratio is […]
Accelerating development of the OTOF-GT and GJB2-GT gene therapy programs in collaboration with Institut Pasteur Advancing SENS-401 joint clinical dev
Cochlear Limited (ASX:COH) and Coles Group Ltd (ASX:COL) shares will be on watch on the ASX 200 on Thursday...
Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent